Navigation Links
Discovery Labs Presents Surfaxin and Aerosurf Data At the Pediatric,Academic Societies' Annual Meeting

upplemental oxygen, which increases their risk of developing BPD. Discovery believes that after an initial RDS treatment, BPD may be successfully treated with repeated doses of a non-immunogenic, precision-engineered synthetic surfactant (Surfaxin) to improve the clinical outcome of these infants.

Discovery's Proprietary KL-4 Surfactant Technology: Product Candidates Surfaxin(r) and Aerosurf(tm)

Discovery's surfactant product candidates, including Surfaxin and Aerosurf, are engineered versions of natural human lung surfactant and contain the precision-engineered KL-4 peptide. KL-4 is a 21 amino acid protein-like substance that is designed to closely mimic the essential attributes of human surfactant protein B (SP-B), the surfactant protein most important for the proper functioning of the respiratory system. KL-4 surfactant has the potential to be precisely formulated, either as a liquid instillate, aerosolized liquid or dry powder, to address various respiratory diseases affecting premature infants, children and adults.

Surfaxin, a precision-engineered Surfactant Replacement Therapy (SRT) administered as a liquid-instillate, represents a potential alternative to animal-derived surfactants. Surfaxin's precision-engineered and non-immunogenic nature allows it to be further developed as a therapeutic to address other pulmonary conditions in neonatal and pediatric medicine. Data from Discovery's pivotal, multinational SELECT study demonstrate that Surfaxin is significantly more effective in the prevention of RDS and results in improved survival (continuing through at least one year of life) and other outcomes versus comparator surfactants. The SELECT and STAR (a supportive Phase 3 study) trials, as well as a pooled Phase 3 analysis, have been presented at several international medical meetings and the results from the two studies were published in Pediatrics.

Aerosurf is a precision-engineered, aerosolized SRT administered via nasal continuou
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
2. Discoverys KL-4 Surfactant Technology Demonstrates Novel Anti-Inflammatory Properties
3. Major Discovery Raises Prospect of Better Patient Care By Improving Platelet Life Span
4. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
5. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
6. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
7. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
8. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
9. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
10. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
11. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
Post Your Comments:
(Date:8/20/2014)... Research and Markets  has announced the addition ... to their offering. Global Market Report of ... globally and regionally ( Europe , ... Latin America etc.). It captures Pralmorelin market ... focuses on three primary areas; manufacture methods & technology development, ...
(Date:8/20/2014)... , Aug. 20, 2014 Research ... the "Global Advanced Wound Care and Closure ... Size, Share, Global Trends, Company Profiles, Demand, Insights, ... - 2020" report to their offering. ... wound care and closure market (types, applications, end ...
(Date:8/20/2014)... Aug. 20, 2014 Reportlinker.com announces that ... its catalogue: Global Coatings for Medical ... This report analyzes the worldwide ... Million by the following Product Segments: Active Coatings, ... report provides separate comprehensive analytics for the US, ...
Breaking Medicine Technology:Global Market Report of Pralmorelin 2Global Advanced Wound Care and Closure Market (Types, Applications, End User and Geography) - Forecast to 2020 2Global Coatings for Medical Devices Industry 2Global Coatings for Medical Devices Industry 3Global Coatings for Medical Devices Industry 4Global Coatings for Medical Devices Industry 5Global Coatings for Medical Devices Industry 6Global Coatings for Medical Devices Industry 7Global Coatings for Medical Devices Industry 8Global Coatings for Medical Devices Industry 9Global Coatings for Medical Devices Industry 10Global Coatings for Medical Devices Industry 11Global Coatings for Medical Devices Industry 12Global Coatings for Medical Devices Industry 13Global Coatings for Medical Devices Industry 14Global Coatings for Medical Devices Industry 15Global Coatings for Medical Devices Industry 16Global Coatings for Medical Devices Industry 17Global Coatings for Medical Devices Industry 18Global Coatings for Medical Devices Industry 19Global Coatings for Medical Devices Industry 20Global Coatings for Medical Devices Industry 21
... Calif., Oct. 11, 2011 Isis Pharmaceuticals, Inc. (NASDAQ: ... designated the second development candidate, ISIS-AATRx, in its collaboration ... million milestone payment from GSK for the selection of ... liver disease caused by alpha-1 antitrypsin deficiency, or AATD, ...
... Va., Oct. 11, 2011 Innocoll, Inc. announces the ... of postoperative adhesions following abdominal and pelvic surgery. The ... of distribution partnerships. The company also plans to seek ... Canada, the MENA region, South East Asia, and to ...
Cached Medicine Technology:Isis Selects Development Candidate, Isis-AATRx, to Treat AATD-Associated Liver Disease 2Isis Selects Development Candidate, Isis-AATRx, to Treat AATD-Associated Liver Disease 3Isis Selects Development Candidate, Isis-AATRx, to Treat AATD-Associated Liver Disease 4Innocoll Announces European Approval for CollaGUARDĀ®, Surgical Adhesion Barrier 2Innocoll Announces European Approval for CollaGUARDĀ®, Surgical Adhesion Barrier 3
(Date:8/20/2014)... Ticket Down is a reliable source for authentic ... just a week, the U.S. Open Tennis Championship will kick off ... originally founded in 1881 and features grass courts since 1978. The ... from the event because of a wrist injury. Serena Williams was ... New York City with hopes of winning her sixth U.S. Open ...
(Date:8/20/2014)... HealthDay Reporter WEDNESDAY, Aug. ... dramatically during the past two decades, plummeting 57 percent and ... An estimated 4 million fewer births occurred among teenagers ... the U.S. Centers for Disease Control and Prevention. That ... report," said Bill Albert, chief program officer of The National ...
(Date:8/20/2014)... patient and tumor characteristics for melanomas with higher ... in an effort to increase earlier detection of ... , Author: Sarah Shen, M.B.B.S., B.Med.Sci., of Alfred ... The tumor characteristic known as mitotic rate ... prognosis and survival in melanoma patients. However, the ...
(Date:8/20/2014)... discovered that the immune system is defective in people suffering ... sufferers have ongoing issues with pain. , The research ... also help to explain why some painkillers may not offer ... up to 10% of the community. There are different ... pain, which often has the greatest impact on sufferers, quality ...
(Date:8/20/2014)... now, Free content, The time to deploy Ebola ... published early online today in Annals of ... of Public Health write that the relentless epidemiologic trajectory ... a public health crisis that shows no signs of ... developed in the last decade, yet the sporadic nature ...
Breaking Medicine News(10 mins):Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 2Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 3Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 4Health News:2014 U.S. Open Tennis Tickets: Ticket Down Slashes Ticket Prices on All US Open Tennis Championship Sessions in New York at Arthur Ashe Stadium 5Health News:Teen Birth Rate Has Dropped Dramatically in Last Two Decades: CDC 2Health News:Teen Birth Rate Has Dropped Dramatically in Last Two Decades: CDC 3Health News:Patient, tumor characteristics for high-mitotic rate melanoma 2Health News:Pain treatments less effective for those with irritable bowel 2Health News:News from Annals of Internal Medicine 2
... December 1, 2009 Adolescent obesity is a major public ... resulting in 4-5 million overweight youth in the United States. ... the Journal of the American Dietetic Association , researchers ... physical activity, comparing overweight adolescents who lost weight and those ...
... Being overweight as a child could lead to early degeneration in ... meeting of the Radiological Society of North America (RSNA). , "This ... mass index (BMI) and disc abnormalities in children," said the study,s ... The Children,s Hospital at Montefiore in New York City. , ...
... Dec. 1 High-frequency ultrasound with elastography can help ... a study presented today at the annual meeting of ... ultrasound with elastography has the potential to improve the ... L. Siegel, M.D., vice chairman of the Department of ...
... 30 HealthPlus of Michigan today announced the launch of ... people looking for affordable benefit choices and convenient access to ... highest-ranked Medicare plans in Michigan, according to the "America,s Best ... Report and the National Committee on Quality Assurance. , ...
... 30 In Massachusetts, approximately 70% of those with Alzheimer,s ... is preparing for a surge in calls to its 24/7 ... filled with opportunities for togetherness and sharing, but for a ... filled with special challenges, according to the experts at the ...
... Nov. 30 Kool Smiles received top honors for ... of InfoWorld ,s Top 100 IT Projects of 2009 ... a Wyse-based thin-client infrastructure to support the electronic health records systems ... this roll-out now complete, Kool Smiles has implemented electronic health records ...
Cached Medicine News:Health News:Investigators identify successful weight control strategies for adolescents 2Health News:Overweight Children may Develop Back Pain and Spinal Abnormalities 2Health News:Special Ultrasound Accurately Identifies Skin Cancer 2Health News:Special Ultrasound Accurately Identifies Skin Cancer 3Health News:HealthPlus Launches New Medicare Advantage Plans 2Health News:HealthPlus Launches New Medicare Advantage Plans 3Health News:Alzheimer's Caregivers Face Holiday Stress 2Health News:Kool Smiles Named Among 2009 InfoWorld 100 2
Express Elyte Systems....
... 2400 has minimal requirements ... low as 2 L/test) ... L/hour) thus maximizing operating ... rack handler facilitates continuous ...
Iron (Total/Ferene). Storage temp: 15 - 30 C. Linearity: 0 - 500 ug/dl. Expected values: from males 60 - 160 ug/dl, from females 43 - 140 ug/dl. Available with Calibrator and Number of test are 120....
Iron UIBC (UIBC Buffer + Color + Std.). An Automated analyzer test kits....
Medicine Products: